Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

We believe that ours is the largest blood biomarker study of preclinical AD to date. These findings underscore the importance of large-scale independent validation of index findings from biomarker studies with relatively small sample sizes.